Research Output per year
Personal profile
Research interests
Dr. Cheng Jiang's research is focused on the cellular and molecular signaling mechanisms relevant to prostate and breast cancer chemoprevention.
Many of her publications deal with identification of herbal chemicals and novel selenium compounds targeting sex hormone signaling related to breast and prostate cancer.
Dr. Jiang has profound bilateral hearing loss and prefers email communications from her collaborators.
Fingerprint Dive into the research topics where Cheng Jiang is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 9 Similar Profiles
Prostatic Neoplasms
Medicine & Life Sciences
Selenium
Medicine & Life Sciences
Apoptosis
Medicine & Life Sciences
Angelica
Medicine & Life Sciences
Pyranocoumarins
Medicine & Life Sciences
Selenious Acid
Medicine & Life Sciences
Neoplasms
Medicine & Life Sciences
Androgen Receptors
Medicine & Life Sciences
Network
Recent external collaboration on country level. Dive into details by clicking on the dots.
Research Output 1992 2019
Optimizing live-animal bioluminescence imaging prediction of tumor burden in human prostate cancer xenograft models in SCID-NSG mice
Kim, S., Zhang, Y., Tang, S., Qin, C., Karelia, D., Sharma, A., Jiang, C. & Lu, J., Jun 15 2019, In : Prostate. 79, 9, p. 949-960 12 p.Research output: Contribution to journal › Article
SCID Mice
Tumor Burden
Luciferases
Heterografts
Prostatic Neoplasms
3
Citations
(Scopus)
Phenylbutyl isoselenocyanate induces reactive oxygen species to inhibit androgen receptor and to initiate p53-mediated apoptosis in LNCaP prostate cancer cells
Wu, W., Karelia, D., Pramanik, K., Amin, S., Sharma, A., Jiang, C. & Lu, J., Aug 1 2018, In : Molecular Carcinogenesis. 57, 8, p. 1055-1066 12 p.Research output: Contribution to journal › Article
Androgen Receptors
Reactive Oxygen Species
Prostatic Neoplasms
Apoptosis
Prostate-Specific Antigen
3
Citations
(Scopus)
Role of p53-senescence induction in suppression of LNCaP prostate cancer growth by cardiotonic compound bufalin
Zhang, Y., Dong, Y., Melkus, M. W., Yin, S., Tang, S. N., Jiang, P., Pramanik, K., Wu, W., Kim, S., Ye, M., Hu, H., Lu, J. & Jiang, C., Nov 1 2018, In : Molecular cancer therapeutics. 17, 11, p. 2341-2352 12 p.Research output: Contribution to journal › Article
Cardiotonic Agents
Prostatic Neoplasms
Growth
Androgen Receptors
Caspases
1
Citation
(Scopus)
Prostate Cancer Xenograft Inhibitory Activity and Pharmacokinetics of Decursinol, a Metabolite of Angelica gigas Pyranocoumarins, in Mouse Models
Wu, W., Tang, S. N., Zhang, Y., Puppala, M., Cooper, T. K., Xing, C., Jiang, C. & Lu, J., Jan 1 2017, In : American Journal of Chinese Medicine. 45, 8, p. 1773-1792 20 p.Research output: Contribution to journal › Article
Pyranocoumarins
Angelica
Heterografts
Prostatic Neoplasms
Pharmacokinetics
25
Citations
(Scopus)
Cancer chemoprevention research with selenium in the post-SELECT era: Promises and challenges
Lu, J., Zhang, J., Jiang, C., Deng, Y., Özten, N. & Bosland, M. C., Jan 2 2016, In : Nutrition and cancer. 68, 1, p. 1-17 17 p.Research output: Contribution to journal › Review article
Selenomethionine
Chemoprevention
Selenium
Yeasts
Research